HEALTH

HEALTH

Coronavirus, bacteria may work together to increase disease severity in some patients: Study

11:32 am September 16, 2020

Houston: The severity of COVID-19 in people with obesity and diabetes may be explained by the combined effects of the novel coronavirus and the body’s natural community of bacteria — the microbiota — working together in the lungs, according to a new study. The review research, published in the journal eLife, assessed mechanisms linking obesity and […]

Read More

AstraZeneca Oxford COVID-19 vaccine trials resume days after pause

10:40 pm September 12, 2020

London: Biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday said that clinical trials for their coronavirus vaccine have resumed in the UK after the Medicines Health Regulatory Authority’s (MHRA) confirmed that the trials were safe. The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants. AstraZeneca […]

Read More

Serum Institute pauses COVID-19 vaccine trials in India

5:44 pm September 10, 2020

New Delhi: Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of ‘an unexplained illness’ in a participant in the study. However, SII on Wednesday said it was continuing with the […]

Read More

‘Significant movement’ on Russia’s request for phase-3 trial, manufacture of Sputnik V in India

8:15 pm September 8, 2020

New Delhi: India is considering Russia’s request for conducting phase-3 clinical trial and manufacturing of its COVID-19 vaccine Sputnik V by Indian firms, officials said Tuesday, noting there has been “significant movement” on both these fronts and specific outcomes are expected soon. Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert […]

Read More

Antibodies against coronavirus stay in body for at least 60 days: Study

10:49 pm September 4, 2020

New Delhi: Asero survey conducted at a leading hospital here over five months has found that the prevalence of antibodies, in a person who has recovered from coronavirus infection, persists for 60-80 days. The survey found that antibodies persisted in the recovered patient’s body for at least 60 days, depending on when the participant was […]

Read More